About Assentus
Assentus is a Healthcare company. Healthcare solutions in pharmaceuticals, focusing on branded generics, nutraceuticals, and wound management in global markets. The company has 15 employees. Its Indian entity Assentus Biogenics Private Limited reported revenue of ₹2.34 Cr. Assentus offers products and services including Wound Management and Nutraceuticals. Its focus areas include Pharmaceuticals, Branded Generics, Nutraceuticals and Medical Services.
Company details
Assentus is recognized as a healthcare entity headquartered in Eastern India, having been established in 2013 to foster compassion and innovation. It is committed to advancing equitable access to affordable, high-quality branded formulations and nutraceuticals, particularly in chronic care and wound management sectors. The company serves Southeast Asian and African markets through WHO-GMP-certified facilities and robust RD, emphasizing universal well-being and lasting community impacts. Dedication to ethical practices is upheld in all operations.
- Employees 15
- SectorsHealthcare
- Email••••••••
- Website assentus.in
- Legal Name Assentus Biogenics Pvt Ltd
- Date of Incorporation 27 Jun, 2013
- Jurisdiction Kolkata, West Bengal, India
- Indian entity revenue₹2.34 Cr
FY 2025 · +3% YoY
- Indian entity net profit₹17.2 Lakh
FY 2025 · 7% margin
- Indian entity EBITDA₹23.4 Lakh
FY 2025 · 10% margin
- Employee Count15
Associated legal entities of Assentus
Assentus operates through Assentus Biogenics Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Assentus Biogenics Private Limited CIN U24100WB2013PTC195114 | Active | 27 Jun 2013 | Kolkata, West Bengal | ₹2.3 Cr | 15 | 3 | View details |
Products & Services of Assentus
Assentus offers a comprehensive portfolio of products and services, including Wound Management and Nutraceuticals.
Solutions for wound treatment, including chronic, burn, acute, and surgical wounds, are provided with a focus on effective healing and quality standards
Formulations for chronic care and other health needs are developed to ensure accessibility and inclusivity across various markets
Board of directors of Assentus Biogenics Private Limited (Assentus)
Assentus Biogenics Private Limited is the primary company behind Assentus. The board of Assentus Biogenics Private Limited currently have 3 directors; the longest-serving is Soumyen Basak, appointed in 2015. 7 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Soumyen Basak DIN 02564357 | Director | 01 Apr 2015 | 11 yrs 7 mo | Assentus Biogenics Private Limited |
| Kabita Basak DIN 06789765 | Additional Director | 27 Feb 2021 | 5 yrs 8 mo | Assentus Biogenics Private Limited |
| Debasis Chakrabarti DIN 02565731 | Director | 30 Sep 2023 | 3 yrs 1 mo | Assentus Biogenics Private Limited |
Financials of Assentus
Figures of Assentus Biogenics Private Limited, the primary company behind Assentus, for FY 2025. Revenue was ₹2.34 Cr (+3% year on year). Net profit was ₹17.2 Lakh (7% margin). EBITDA was ₹23.4 Lakh (10% margin). Revenue has grown at a compounded annual rate of +35% over three years and +15% over five years.
- ₹2.34 CrRevenue · FY 2025 · +3% YoY
- ₹17.2 LakhNet profit · 7% margin
- ₹23.4 LakhEBITDA · 10% margin
- ₹59.5 LakhPaid-up capital
- 15Employees (provident fund records)
- +35%Revenue CAGR, 3 years
- +15%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Assentus Biogenics Private Limited are on its company page.
Detailed financial statements for Assentus
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Assentus
Assentus has 15 employees.
The primary company behind Assentus, Assentus Biogenics Private Limited, reported revenue of ₹2.34 Cr for FY 2025, up 3% year on year.
Assentus is recognized as a healthcare entity headquartered in Eastern India, having been established in 2013 to foster compassion and innovation. It is committed to advancing equitable access to affordable, high-quality branded formulations and nutraceuticals, particularly in chronic care and wound management sectors. The company serves Southeast Asian and African markets through WHO-GMP-certified facilities and robust RD, emphasizing universal well-being and lasting community impacts. Dedication to ethical practices is upheld in all operations.
Assentus offers Wound Management and Nutraceuticals.
Assentus operates through Assentus Biogenics Private Limited.
The legal entities of Assentus currently have 3 directors, including Soumyen Basak, Kabita Basak, Debasis Chakrabarti.